Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|April 6, 2010
Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancerEmmanuel Mitry, Pascal Hammel, Gaël Deplanque, et al.
Nature Cell Biology|May 31, 2006
Amplification of CRAC current by STIM1 and CRACM1 (Orai1)Christine Peinelt, Monika Vig, Dana L Koomoa, et al.
The Journal of Allergy and Clinical Immunology|August 21, 2021
A novel functional mast cell assay for the detection of allergiesNoemi Zbären, Daniel Brigger, Daniel Bachmann, et al.
Plos One|January 28, 2016
T Cell Receptor Mediated Calcium Entry Requires Alternatively Spliced Cav1.1 ChannelsDidi Matza, Abdallah Badou, Kathryn G Klemic, et al.
Current Biology : CB|September 19, 2006
CRACM1 multimers form the ion-selective pore of the CRAC channelMonika Vig, Andreas Beck, James M Billingsley, et al.
Alzheimer'S Research & Therapy|April 21, 2011
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trialFrançois Piette, Joël Belmin, Hélène Vincent, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2010
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST)Axel Le Cesne, Jean-Yves Blay, Binh Nguyen Bui, et al.
The Journal of Experimental Medicine|October 5, 2011
Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malariaAdeline Porcherie, Cedric Mathieu, Roger Peronet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2012
The TRPM4 channel controls monocyte and macrophage, but not neutrophil, function for survival in sepsisNicolas Serafini, Albert Dahdah, Gaëtan Barbet, et al.
Pageof 5